Stocks to Watch Today: RVNL, Cohance Lifesciences, Molbio Diagnostics and Others (September 7, 2026)

Indian stocks are likely to remain focused on company-specific developments today, with fresh orders, regulatory updates, fundraising plans, business launches and bulk deals expected to influence trading activity. 

Rail Vikas Nigam Ltd 

Rail Vikas Nigam has received a Letter of Award from SJVN Thermal for the construction of a permanent siding along with an aerial connection via track from the plant boundary to Chausa and Pawani Kamarpur in Buxar, Bihar. The project forms part of Phase III of the 1,320 MW Buxar Thermal Power Project and is valued at ₹903 crore. 

Cohance Lifesciences Ltd 

The United States Food and Drug Administration inspected Cohance Lifesciences' formulation plant in Shamshabad, Telangana, between August 27, 2026 and September 4, 2026. The inspection concluded with the issuance of a Form FDA 483 containing four observations. The development will remain in focus as investors assess the observations and their potential implications. 

Molbio Diagnostics Ltd 

Molbio Diagnostics reported a consolidated profit of ₹58.7 crore for the quarter, compared with a loss of ₹23.7 crore in the corresponding period. Revenue increased nearly four-fold to ₹408.4 crore from ₹99.7 crore, putting the company in focus following the strong year-on-year improvement. 

Tata Motors Commercial Vehicles 

TML CV Holdings B.V., a subsidiary of Tata Motors, has commenced a voluntary tender offer for all issued common shares of Iveco Group at EUR 14.1 per share in cash, including dividend. The offer values Iveco Group at approximately EUR 3.82 billion. The tender offer will remain open from September 7 to October 26, 2026. 

Mazagon Dock Shipbuilders Ltd 

Maharashtra State Electricity Transmission Company has placed a purchase order worth ₹118 crore with Mazagon Dock Shipbuilders for the supply, installation and commissioning of an AI-based comprehensive infrasecure project covering five substations. 

Prime Focus Ltd 

The Board of Prime Focus has approved a proposal to raise up to ₹3,000 crore through the issuance of equity shares or debt securities. The proposed fundraising will be closely watched as investors assess its potential impact on the company's capital structure and future expansion plans. 

Lupin Ltd 

Lupin has received approval from the United States Food and Drug Administration for Modafinil Tablets USP in 100 mg and 200 mg strengths. The tablets are bioequivalent to Provigil Tablets of Nuvo Pharmaceuticals (Ireland) DAC and are indicated for improving wakefulness in adults with excessive sleepiness associated with narcolepsy, obstructive sleep apnea or shift work disorder. The product had estimated annual US sales of $70.7 million, according to IQVIA MAT data for July 2026. 

Brigade Enterprises Ltd 

Brigade Group has announced the launch of Brigade Barcelona in Neopolis, Hyderabad. The premium residential project is spread across 4.04 acres and has an estimated revenue potential of more than ₹2,700 crore. 

Urban Enviro Waste Management Ltd 

Urban Enviro Waste Management has received an order worth ₹219 crore from Akola Municipal Corporation for door-to-door collection and transportation of municipal solid waste to the designated processing and disposal site at Bhod. The contract is for five years and can be extended by up to two years. 

Read More: JSW Steel Share Price in Focus; August Crude Steel Production Rises to 24.65 Lakh Tonnes! 

Swiggy Ltd 

BNP Paribas Financial Markets bought 1.78 crore shares of Swiggy for ₹491.99 crore, while Goldman Sachs Investments Mauritius I purchased 1.98 crore shares for ₹549.01 crore. The transactions together represented a 1.36% stake in the company, with the shares purchased at ₹276.10 apiece. 

Shankara Buildpro Ltd 

Ohana India Growth Fund acquired an additional 1.64% stake in Shankara Buildpro for ₹51.88 crore through two transactions. The fund purchased 2 lakh shares at ₹1,296.99 per share and another 2 lakh shares at ₹1,297 per share. 

Gland Pharma Ltd 

Promoter Fosun Pharma Industrial sold 75.05 lakh shares, representing a 4.5% stake in Gland Pharma, for ₹2,121.5 crore at ₹2,826.60 per share. The shares were acquired by 11 institutional investors. Fosun Pharma Industrial held a 51.77% stake in the company as of June 2026. 

Purple Style Labs, Ashutosh Fibre and Other Listings 

Purple Style Labs is scheduled for its Mainboard listing, while Ashutosh Fibre, Shanti Inorganics and Phychem Technologies are also set to make their SME listing. These listings will be watched for their opening performance and investor participation. 

Nava Ltd 

Nava has temporarily shut down one 60 MW independent power producer unit from September 6, 2026, for routine inspection, maintenance and overhauling. The shutdown is expected to last around 55 to 60 days. The company does not expect any material adverse impact on its business operations or overall performance. 

Conclusion 

Fresh railway and municipal orders, regulatory developments, fundraising plans, strong quarterly numbers and large block transactions are likely to drive stock-specific action in today's trading session. Investors will also track new listings and developments across the pharmaceutical, infrastructure, technology and renewable business segments. 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks. Read all related documents carefully before investing.